Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression

Clinical trial NCT05683964 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05683964
Sponsor: Beth Israel Deaconess Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Prostate Adenocarcinoma Prostate Cancer Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Start date: 2023-01-19
Primary completion: 2025-09-18
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.